col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


54 Results       Page 1

 [1] 
Wiley: Research and Practice in Thrombosis and Haemostasis
  original article Date Title Authors   All Authors
1 [GO] 2022―May―18 Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial Marc Blondon, Sara Cereghetti, Jérôme Pugin, Christophe Marti, Pauline Darbellay Farhoumand, Jean-Luc Reny, et al. (+13)
2 [GO] 2022―May―02 Platelet-leukocyte interactions in COVID-19: Contributions to hypercoagulability, inflammation, and disease severity Eugenio D. Hottz, Patrícia T. Bozza
3 [GO] 2022―Apr―20 Risk of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination prior to the recognition of vaccine-induced thrombocytopenia and thrombosis: A self-controlled case series study in England Hannah Higgins, Nick Andrews, Julia Stowe, Gayatri Amirthalingam, Mary Ramsay, Gurpreet Bahra, et al. (+17)
4 [GO] 2022―Apr―15 Coagulation factor inhibitors in COVID-19: From SARS-CoV-2 vaccination to infection Jeremy W. Jacobs, Brian D. Adkins, Shannon C. Walker, Garrett S. Booth, Allison P. Wheeler
5 [GO] 2022―Apr―05 Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosing Matthias M. Engelen, Christophe Vandenbriele, Valérie Spalart, Caroline P. Martens, Bert Vandenberk, Pieter Sinonquel, et al. (+14)
6 [GO] 2022―Mar―21 MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A retrospective cohort study Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Dudley Benjamin Christie, Sarah Orfanos, Lorenzo Anez-Bustillos, et al. (+26)
7 [GO] 2022―Feb―16 COVID-19 and venous thromboembolism: A narrative review Dana E. Angelini, Scott Kaatz, Rachel P. Rosovsky, Rebecca L. Zon, Shreejith Pillai, William E. Robertson, et al. (+3)
8 [GO] 2022―Feb―08 Clinical relapse of immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination William Deucher, Senthil Sukumar, Spero R. Cataland
9 [GO] 2022―Jan―15 Thromboelastography determined dynamics of blood coagulation and its correlation with complications and outcomes in patients with coronavirus disease 2019 Tushar Sehgal, Mukul Aggarwal, Upendra Baitha, Gaurav Gupta, Bindu Prakash, Anu Gupta, et al. (+3)
10 [GO] 2022―Jan―15 Vaccine-induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV-19 is rare in Asia Kochawan Boonyawat, Pantep Angchaisuksiri
11 [GO] 2021―Dec―17 Randomized trials of therapeutic heparin for COVID-19: A meta-analysis Michelle Sholzberg, Bruno R. Costa, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, et al. (+13)
12 [GO] 2021―Nov―21 Safety of the second dose of the ChAdOx1 nCoV-19 vaccine in people with persistent anti-platelet factor 4 antibodies Noppacharn Uaprasert, Sasinipa Trithiphen, Autcharaporn Sukperm, Benjaporn Akkawat, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, et al. (+4)
13 [GO] 2021―Nov―03 The path of uncovering a prothrombotic thrombocytopenic syndrome after viral vector-based COVID-19 vaccination: Where there is much light, the shadow is deep Johannes Thaler, Cihan Ay, Paul Knoebl
14 [GO] 2021―Oct―16 Stability of vitamin K antagonist anticoagulation after COVID-19 diagnosis Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter
15 [GO] 2021―Oct―12 Prevalence of anti-platelet factor 4/polyanionic antibodies after COVID-19 vaccination with ChAdOx1 nCoV-19 and CoronaVac in Thais Phichchapha Noikongdee, Pornnapa Police, Tichayapa Phojanasenee, Pichika Chantrathammachart, Pimjai Niparuck, Teeraya Puavilai, et al. (+3)
16 [GO] 2021―Sep―25 Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge Anne-Marije Hulshof, Dionne C. W. Braeken, Chahinda Ghossein-Doha, Susanne van Santen, Jan-Willem E. M. Sels, Gerhardus J. A. J. M. Kuiper, et al. (+5)
17 [GO] 2021―Sep―18 Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies and D-dimer elevation in Thai people After ChAdOx1 nCoV-19 vaccination Noppacharn Uaprasert, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, Sasinipa Trithiphen, Benjaporn Akkawat, Autcharaporn Sukperm, et al. (+4)
18 [GO] 2021―Sep―13 Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis Golzar Mobayen, Amrita Dhutia, Candice Clarke, Maria Prendecki, Stephen McAdoo, Renos Keniyopoullos, et al. (+4)
19 [GO] 2021―Aug―25 Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine-A case report Bader Al Rawahi, Hashem BaTaher, Zoheb Jaffer, Aya Al-Balushi, Asma Al-Mazrouqi, Noof Al-Balushi
20 [GO] 2021―Jun―28 Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors Alex C. Spyropoulos, Dimitrios Giannis, Mark Goldin
21 [GO] 2021―May―19 Comparison of the coagulopathies associated with COVID-19 and sepsis Robert A. Campbell, Yohei Hisada, Frederik Denorme, Steven P. Grover, Emma G. Bouck, Elizabeth A. Middleton, et al. (+3)
22 [GO] 2021―May―08 Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study Lachelle D. Weeks, Katelyn W. Sylvester, Jean M. Connors, Nathan T. Connell
23 [GO] 2021―Mar―08 Caging the dragon: Research approach to COVID-19-related thrombosis Marieke J. H. A. Kruip, Suzanne C. Cannegieter, Hugo ten Cate, Eric C. M. Gorp, Nicole P. Juffermans, Frederikus A. Klok, et al. (+2)
24 [GO] 2021―Feb―24 Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19 Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, et al. (+6)
25 [GO] 2021―Feb―18 Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients MAM Stals, MJJH Grootenboers, C van Guldener, FHJ Kaptein, SJE Braken, Q Chen, et al. (+10)
26 [GO] 2021―Jan―15 Vascular thromboembolic events following COVID-19 hospital discharge: incidence and risk factors Harish Eswaran, Jamie A. Jarmul, Amy W. Shaheen, David Meaux, Tristan Long, Derek Saccoccio, Stephan Moll
27 [GO] 2021―Jan―05 COVID-19-related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy Alice Assinger
28 [GO] 2020―Dec―07 Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality Fien A. Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Ann-Sofie Rudberg, Maria Magnusson, et al. (+3)
29 [GO] 2020―Nov―10 eThrombosis: A new risk factor for venous thromboembolism in the pandemic era Daisuke Sueta, Koichi Kaikita, Kenichi Matsushita, Kenichi Tsujita
30 [GO] 2020―Oct―21 Harmonizing Hypercoagulable Heterogeneity: Baseline VTE Risk in COVID-19 George Goshua, Alfred Ian Lee
31 [GO] 2020―Sep―28 COVID-19 pandemic perspectives: A scientific silver lining? Dre'Von A. Dobson, Alisa S. Wolberg
32 [GO] 2020―Sep―25 Thrombo-inflammation response to Tocilizumab in COVID-19 Mansour Gergi, Mary Cushman, Benjamin Littenberg, Ralph C. Budd
33 [GO] 2020―Sep―25 Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis Stephan Nopp, Florian Moik, Bernd Jilma, Ingrid Pabinger, Cihan Ay
34 [GO] 2020―Sep―19 Left ventricular thrombus and pulmonary embolism: A case series of thrombosis in COVID-19 in Thai patients Nithita Nanthatanti, Sithakom Phusanti, Pichika Chantrathammachart, Kanin Thammavaranucupt, Pantep Angchaisuksiri, Somnuek Sungkanuparph
35 [GO] 2020―Jul―14 The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19 Jori E. May, Rance C. Siniard, Marisa Marques
36 [GO] 2020―Jul―11 Thrombosis and coagulopathy in COVID-19: An illustrated review Marcel Levi, Beverley J. Hunt
37 [GO] 2020―Jul―09 Response to The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19 Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder
38 [GO] 2020―Jul―09 Anticoagulation Practice Patterns in COVID-19: A Global Survey Rachel P. Rosovsky, Kristen M Sanfilippo, Tzu Fei Wang, Sandeep K. Rajan, Surbhi Shah, Karlyn A. Martin, et al. (+8)
39 [GO] 2020―Jun―25 Staying updated on COVID-19: social media to amplify science in thrombosis and haemostasis Mike Makris
40 [GO] 2020―Jun―14 The underrecognized prothrombotic vascular disease of COVID-19 Kevin P. Cohoon, Guillaume Mahé, Alex C. Spyropoulos
41 [GO] 2020―Jun―08 Gender gap in women authors is not worse during COVID-19 pandemic: Results from Research and Practice in Thrombosis and Haemostasis Mary Cushman
42 [GO] 2020―May―29 Anticoagulation, Immortality, and Observations of COVID-19 Jason H. Maley, Camille R. Petri, Laura N. Brenner, Raghu R. Chivukula, Tiara F. Calhoun, Vladimir Vinarsky, C. Corey Hardin
43 [GO] 2020―May―29 Potential Role of Platelets in COVID-19: Implications for Thrombosis Milka Koupenova
44 [GO] 2020―May―21 STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial Hunter B. Moore, Christopher D. Barrett, Ernest E. Moore, Rashi Jhunjhnuwala, Robert C. McIntyre, Peter K Moore, et al. (+5)
45 [GO] 2020―May―20 Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 Adult Respiratory Distress Syndrome Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder
46 [GO] 2020―May―20 Pulmonary embolism during the COVID-19 pandemic: decline in diagnostic procedures and incidence at a University Hospital Stephan Nopp, Karin Janata-Schwatczek, Helmut Prosch, Ihor Shulym, Oliver Königsbrügge, Ingrid Pabinger, Cihan Ay
47 [GO] 2020―May―14 Venous Thromboembolism in Critically Ill Patients with Covid-19: Results of a Screening Study for Deep Vein Thrombosis Alban Longchamp, Justine Longchamp, Sara Manzocchi-Besson, Livia Whiting, Claude Haller, Séverin Jeanneret, et al. (+16)
48 [GO] 2020―May―11 A Proposal for Staging COVID-19 Coagulopathy Jecko Thachil, Mary Cushman, Alok Srivastava
49 [GO] 2020―May―06 Thrombosis and Thromboembolism Related to COVID-19 A clarion call for obtaining solid estimates from large-scale multicenter data Stefano Barco, Stavros V Konstantinides
50 [GO] 2020―May―04 COVID-19 Hypothesis: Activated Protein C for Therapy of Virus-induced Pathologic Thromboinflammation John H. Griffin, Patrick Lyden
51 [GO] 2020―Apr―28 Fibrinolytic Therapy for Refractory COVID-19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Robert C. McIntyre, Peter K Moore, John Burke, et al. (+7)
52 [GO] 2020―Apr―28 Emergence of Institutional Antithrombotic Protocols for Coronavirus 2019 Kevin P. Cohoon, Guillaume Mahé, Alfonso J. Tafur, Alex C. Spyropoulos
53 [GO] 2020―Apr―21 COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance Suzanne C Cannegieter, Frederikus A Klok
54 [GO] 2020―Apr―18 The Contact Activation System as a Potential Therapeutic Target in Patients with COVID-19 JJ Shatzel, EP DeLoughery, CU Lorentz, EI Tucker, JE Aslan, MT Hinds, et al. (+4)
 [1] 

54 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec